Fulgent Genetics (FLGT) Non-Current Assets (2015 - 2026)

Fulgent Genetics has disclosed Non-Current Assets across 12 years of filings, most recently posting $634.5 million for Q2 2026.

• In Q2 2026, Non-Current Assets fell 17.72% year-over-year to $634.5 million; the TTM figure through Jun 2026 stood at $2.7 billion (down 19.55% YoY), while the FY2025 annual figure was $663.0 million, down 23.47% from the prior year.
• Non-Current Assets came in at $634.5 million for Q2 2026 at Fulgent Genetics, down from $677.3 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $907.2 million in Q3 2024 to a low of $634.5 million in Q2 2026.
• Average Non-Current Assets over 5 years is $766.9 million, with a median of $778.8 million recorded in 2022.
• Year-over-year, Non-Current Assets surged 105.99% in 2022 and slipped 23.47% in 2025.
• Over 5 years, Non-Current Assets stood at $758.2 million in 2022, then retreated by 4.05% to $727.5 million in 2023, then grew by 19.09% to $866.4 million in 2024, then fell by 23.47% to $663.0 million in 2025, then retreated by 4.31% to $634.5 million in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $634.5 million in Q2 2026, $677.3 million in Q1 2026, and $663.0 million in Q4 2025.